Literature DB >> 32408830

Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.

David N Firmin1,2, Dudley J Pennell1,2, Zohya Khalique1,2, Pedro F Ferreira1,2, Andrew D Scott1,2, Sonia Nielles-Vallespin1,2, Ana Martinez-Naharro3, Marianna Fontana3, Phillip Hawkins3.   

Abstract

Background Cardiac amyloidosis (CA) is a disease of interstitial myocardial infiltration, usually by light chains or transthyretin. We used diffusion tensor cardiovascular magnetic resonance (DT-CMR) to noninvasively assess the effects of amyloid infiltration on the cardiac microstructure. Methods DT-CMR was performed at diastole and systole in 20 CA, 11 hypertrophic cardiomyopathy, and 10 control subjects with calculation of mean diffusivity, fractional anisotropy, and sheetlet orientation (secondary eigenvector angle). Results Mean diffusivity was elevated and fractional anisotropy reduced in CA compared with both controls and hypertrophic cardiomyopathy (P<0.001). In CA, mean diffusivity was correlated with extracellular volume (r=0.68, P=0.004), and fractional anisotropy was inversely correlated with circumferential strain (r=-0.65, P=0.02). In CA, diastolic secondary eigenvector angle was elevated, and secondary eigenvector angle mobility was reduced compared with controls (both P<0.001). Diastolic secondary eigenvector angle was correlated with amyloid burden measured by extracellular volume in transthyretin, but not light chain amyloidosis. Conclusions DT-CMR can characterize the microstructural effects of amyloid infiltration and is a contrast-free method to identify the location and extent of the expanded disorganized myocardium. The diffusion biomarkers mean diffusivity and fractional anisotropy effectively discriminate CA from hypertrophic cardiomyopathy. DT-CMR demonstrated that failure of sheetlet relaxation in diastole correlated with extracellular volume in transthyretin, but not light chain amyloidosis. This indicates that different mechanisms may be responsible for impaired contractility in CA, with an amyloid burden effect in transthyretin, but an idiosyncratic effect in light chain amyloidosis. Consequently, DT-CMR offers a contrast-free tool to identify novel pathophysiology, improve diagnostics, and monitor disease through noninvasive microstructural assessment.

Entities:  

Keywords:  amyloid; diffusion tensor imaging; extracellular space; magnetic resonance imaging; myocardium

Mesh:

Year:  2020        PMID: 32408830      PMCID: PMC7255887          DOI: 10.1161/CIRCIMAGING.119.009901

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  35 in total

Review 1.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

2.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

3.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

Review 4.  Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?

Authors:  Ruth H Willott; Aldrin V Gomes; Audrey N Chang; Michelle S Parvatiyar; Jose Renato Pinto; James D Potter
Journal:  J Mol Cell Cardiol       Date:  2009-11-12       Impact factor: 5.000

5.  Challenging the myths of cardiac amyloidosis.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Eur Heart J       Date:  2017-06-21       Impact factor: 29.983

6.  Optimal diffusion weighting for in vivo cardiac diffusion tensor imaging.

Authors:  Andrew D Scott; Pedro F A D C Ferreira; Sonia Nielles-Vallespin; Peter Gatehouse; Laura-Ann McGill; Philip Kilner; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2014-08-22       Impact factor: 4.668

7.  In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.

Authors:  Pedro F Ferreira; Philip J Kilner; Laura-Ann McGill; Sonia Nielles-Vallespin; Andrew D Scott; Siew Y Ho; Karen P McCarthy; Margarita M Haba; Tevfik F Ismail; Peter D Gatehouse; Ranil de Silva; Alexander R Lyon; Sanjay K Prasad; David N Firmin; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2014-11-12       Impact factor: 5.364

8.  Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.

Authors:  Alexander Gotschy; Constantin von Deuster; Robbert J H van Gorkum; Mareike Gastl; Ella Vintschger; Rahel Schwotzer; Andreas J Flammer; Robert Manka; Christian T Stoeck; Sebastian Kozerke
Journal:  J Cardiovasc Magn Reson       Date:  2019-09-05       Impact factor: 5.364

9.  Magnetic Resonance in Transthyretin Cardiac Amyloidosis.

Authors:  Ana Martinez-Naharro; Thomas A Treibel; Amna Abdel-Gadir; Heerajnarain Bulluck; Giulia Zumbo; Daniel S Knight; Tushar Kotecha; Rohin Francis; David F Hutt; Tamer Rezk; Stefania Rosmini; Candida C Quarta; Carol J Whelan; Peter Kellman; Julian D Gillmore; James C Moon; Philip N Hawkins; Marianna Fontana
Journal:  J Am Coll Cardiol       Date:  2017-07-25       Impact factor: 24.094

10.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

View more
  7 in total

Review 1.  Cardiac Magnetic Resonance Quantification of Structure-Function Relationships in Heart Failure.

Authors:  Kim-Lien Nguyen; Peng Hu; J Paul Finn
Journal:  Heart Fail Clin       Date:  2020-10-28       Impact factor: 3.179

2.  Characterization of cardiac amyloidosis using cardiac magnetic resonance fingerprinting.

Authors:  Brendan L Eck; Nicole Seiberlich; Scott D Flamm; Jesse I Hamilton; Abhilash Suresh; Yash Kumar; Mazen Hanna; Angel Houston; Derrek Tew; W H Wilson Tang; Deborah H Kwon
Journal:  Int J Cardiol       Date:  2021-12-25       Impact factor: 4.164

Review 3.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

4.  Phenotyping of Cardiac Amyloidosis: Advancing From Macro to Micro?

Authors:  Sarah Cuddy; Michael Jerosch-Herold; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2020-05-15       Impact factor: 7.792

5.  Comparison of interpolation methods of predominant cardiomyocyte orientation from in vivo and ex vivo cardiac diffusion tensor imaging data.

Authors:  Johanna Stimm; Christian Guenthner; Sebastian Kozerke; Christian T Stoeck
Journal:  NMR Biomed       Date:  2021-12-29       Impact factor: 4.478

6.  Evaluation of Right Ventricular Function and Myocardial Microstructure in Fetal Hypoplastic Left Heart Syndrome.

Authors:  Jing Ma; Yaping Yuan; Li Zhang; Shizhen Chen; Haiyan Cao; Liu Hong; Juanjuan Liu; Xiaoyan Song; Jiawei Shi; Yi Zhang; Li Cui; Xin Zhou; Mingxing Xie
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

Review 7.  Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia.

Authors:  Weiqin Lin; Pairoj Chattranukulchai; Alex Pw Lee; Yen-Hung Lin; Wen-Chung Yu; Houng-Bang Liew; Abraham Oomman
Journal:  Clin Cardiol       Date:  2022-07-06       Impact factor: 3.287

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.